2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone has been researched along with Nausea in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedikian, AY; Bodey, GP; Burgess, MA; Yap, BS | 1 |
| Christ, M; Haid, M; Hatfield, A; Johnson, CM; Khandekar, JD; Lanzotti, V; Locker, GY; Merrill, JM; Miller, SJ; Reisel, H | 1 |
2 other study(ies) available for 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Nausea
| Article | Year |
|---|---|
AZQ therapy in patients with disseminated malignant melanoma.
Topics: Adult; Aged; Anorexia; Aziridines; Azirines; Benzoquinones; Bone Marrow; Cyclohexenes; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Nausea; Thrombocytopenia; Vomiting | 1982 |
Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A Phase II study by the Illinois Cancer Council.
Topics: Adolescent; Adult; Aged; Anemia; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Cyclohexenes; Drug Evaluation; Glioma; Humans; Leukopenia; Middle Aged; Nausea; Radiography; Vomiting | 1985 |